Today I received the following e-mail and press release from Dendreon's Senior Director for Government Affairs, Chris Lockett. At this time the FDA did not grant Dendreon a license to market its immunologic therapy Provenge! The FDA has requested additional information from Dendreon pertaining to data which would support its efficacy as well as information [...]
For years, the pharmaceutical companies have been developing more then just drugs! Our treating physicians and our researchers have also been very creative, performing feats beyond what we normally give them credit. Together, they have created a cadre of patients who are guilty of not measuring up to the task while also avoiding any responsibility [...]
We hear a lot in the press about the celebrity survivors and how they stand up and fight their cancer. They all are the benefactors of cutting edge treatments and the very best doctors. However, we never hear about the little guy, the guy without insurance who will often receive substandard treatment, or no treatment. [...]
I went to the United Parcel Service terminal this afternoon to ship a carton to my nephew in Philadelphia. Standing next to me was an older women just chatting away with the counter person. She was speaking very loudly, so it was hard not listen. She was complaining away. She went on about how hard [...]
The following was submitted to the FDA in support of the development of additional treatments for men with advanced prostate cancer, including Provenge. The advocates of "Raise a Voice", a grass roots initiative for advanced prostate cancer, would like to express our appreciation for the opportunity to present comments at the Cellular, Tissue and [...]